Cargando…

Risk factors of pneumonia in persons with and without Alzheimer’s disease: a matched cohort study

BACKGROUND: Pneumonia is a very common infection in the cognitively impaired adult population, often leading to long-term deterioration, in physical and cognitive performance. Evidence is lacking on whether chronic comorbidities and drug use are risk factors for pneumonia in persons with Alzheimer’s...

Descripción completa

Detalles Bibliográficos
Autores principales: Järvinen, Heli, Tolppanen, Anna-Maija, Hartikainen, Sirpa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084638/
https://www.ncbi.nlm.nih.gov/pubmed/37038120
http://dx.doi.org/10.1186/s12877-023-03940-z
_version_ 1785021781056159744
author Järvinen, Heli
Tolppanen, Anna-Maija
Hartikainen, Sirpa
author_facet Järvinen, Heli
Tolppanen, Anna-Maija
Hartikainen, Sirpa
author_sort Järvinen, Heli
collection PubMed
description BACKGROUND: Pneumonia is a very common infection in the cognitively impaired adult population, often leading to long-term deterioration, in physical and cognitive performance. Evidence is lacking on whether chronic comorbidities and drug use are risk factors for pneumonia in persons with Alzheimer’s disease (AD). The objective of this study was to investigate the risk factors of pneumonia in community dwellers with and without AD. METHODS: We performed a retrospective register-based study utilizing the Medication Use and Alzheimer’s disease (MEDALZ) cohort, which is based on Finnish nationwide healthcare registers and includes all community dwellers who received a verified clinical diagnosis of AD between 2005 to 2011. This study comprised 69,350 persons with AD and 69,350 persons without AD matched by age, gender, and region of residence. Association between comorbidities, drug use, and hospitalization due to pneumonia were assessed using Cox Regression. RESULTS: During the follow-up, 25.0% (n = 17,105) of the AD cohort and 15.8% (n = 10,966) of the non-AD cohort were hospitalized due to pneumonia. Persons with AD had a higher risk of pneumonia also after adjusting for comorbidities (HR 1.76, 95% CI 1.71–1.80). Previous pneumonia was the strongest risk factor for pneumonia in both cohorts. All comorbidities and drug use excluding biological product use were associated with a higher risk of pneumonia, but stronger associations were observed in the non-AD cohort. The risk of hospitalization following psychotropic drug use was proportional to the number of psychotropics utilized. CONCLUSIONS: Pneumonia is a serious, potentially life-threatening illness, and risk factors for pneumonia include several potentially avoidable drugs. In addition, good care of existing comorbidities might prevent pneumonia and related hospitalization. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-023-03940-z.
format Online
Article
Text
id pubmed-10084638
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100846382023-04-11 Risk factors of pneumonia in persons with and without Alzheimer’s disease: a matched cohort study Järvinen, Heli Tolppanen, Anna-Maija Hartikainen, Sirpa BMC Geriatr Research BACKGROUND: Pneumonia is a very common infection in the cognitively impaired adult population, often leading to long-term deterioration, in physical and cognitive performance. Evidence is lacking on whether chronic comorbidities and drug use are risk factors for pneumonia in persons with Alzheimer’s disease (AD). The objective of this study was to investigate the risk factors of pneumonia in community dwellers with and without AD. METHODS: We performed a retrospective register-based study utilizing the Medication Use and Alzheimer’s disease (MEDALZ) cohort, which is based on Finnish nationwide healthcare registers and includes all community dwellers who received a verified clinical diagnosis of AD between 2005 to 2011. This study comprised 69,350 persons with AD and 69,350 persons without AD matched by age, gender, and region of residence. Association between comorbidities, drug use, and hospitalization due to pneumonia were assessed using Cox Regression. RESULTS: During the follow-up, 25.0% (n = 17,105) of the AD cohort and 15.8% (n = 10,966) of the non-AD cohort were hospitalized due to pneumonia. Persons with AD had a higher risk of pneumonia also after adjusting for comorbidities (HR 1.76, 95% CI 1.71–1.80). Previous pneumonia was the strongest risk factor for pneumonia in both cohorts. All comorbidities and drug use excluding biological product use were associated with a higher risk of pneumonia, but stronger associations were observed in the non-AD cohort. The risk of hospitalization following psychotropic drug use was proportional to the number of psychotropics utilized. CONCLUSIONS: Pneumonia is a serious, potentially life-threatening illness, and risk factors for pneumonia include several potentially avoidable drugs. In addition, good care of existing comorbidities might prevent pneumonia and related hospitalization. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-023-03940-z. BioMed Central 2023-04-10 /pmc/articles/PMC10084638/ /pubmed/37038120 http://dx.doi.org/10.1186/s12877-023-03940-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Järvinen, Heli
Tolppanen, Anna-Maija
Hartikainen, Sirpa
Risk factors of pneumonia in persons with and without Alzheimer’s disease: a matched cohort study
title Risk factors of pneumonia in persons with and without Alzheimer’s disease: a matched cohort study
title_full Risk factors of pneumonia in persons with and without Alzheimer’s disease: a matched cohort study
title_fullStr Risk factors of pneumonia in persons with and without Alzheimer’s disease: a matched cohort study
title_full_unstemmed Risk factors of pneumonia in persons with and without Alzheimer’s disease: a matched cohort study
title_short Risk factors of pneumonia in persons with and without Alzheimer’s disease: a matched cohort study
title_sort risk factors of pneumonia in persons with and without alzheimer’s disease: a matched cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084638/
https://www.ncbi.nlm.nih.gov/pubmed/37038120
http://dx.doi.org/10.1186/s12877-023-03940-z
work_keys_str_mv AT jarvinenheli riskfactorsofpneumoniainpersonswithandwithoutalzheimersdiseaseamatchedcohortstudy
AT tolppanenannamaija riskfactorsofpneumoniainpersonswithandwithoutalzheimersdiseaseamatchedcohortstudy
AT hartikainensirpa riskfactorsofpneumoniainpersonswithandwithoutalzheimersdiseaseamatchedcohortstudy